Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.76
Delayed Data
As of 4:02pm ET
 -0.22 / -0.54%
Today’s Change
37.24
Today|||52-Week Range
49.08
+1.02%
Year-to-Date

Today’s Trading

Previous close40.98
Today’s open40.93
Day’s range40.46 - 40.95
Volume3,431,421
Average volume (3 months)3,739,009
Market cap$99.8B
Dividend yield5.91%
Data as of 4:02pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-22.80%
Earnings growth (next 5 years)+4.10%
Revenue growth (last year)-8.75%
P/E ratio10.1
Price/Sales2.74
Price/Book14.99

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.07-0.12%
NVONovo Nordisk-0.75-1.51%
SNYSanofi-0.77-1.90%
ABBVAbbVie-3.64-6.41%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 27, 2016
EPS forecast (this quarter)$0.58
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers